KCNG3 IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with KCNG3 IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with KCNG3 IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with KCNG3 IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KCNG3 IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

MT-CO2 pseudogene 12

Gene

long intergenic non-protein coding RNA 680

Gene

BRAF pseudogene 1

Gene

CTAGE family member 14, pseudogene

Gene

zinc finger protein 962, pseudogene

Gene

olfactory receptor family 7 subfamily E member 148 pseudogene

Gene

HHLA1 neighbor of OC90

Gene

zinc finger protein 398

Gene

CECR2 histone acetyl-lysine reader

Gene

cystathionine beta-synthase like

  • Gene

    MT-CO2 pseudogene 12


  • Gene

    long intergenic non-protein coding RNA 680


  • Gene

    BRAF pseudogene 1


  • Gene

    CTAGE family member 14, pseudogene


  • Gene

    zinc finger protein 962, pseudogene


  • Gene

    olfactory receptor family 7 subfamily E member 148 pseudogene


  • Gene

    HHLA1 neighbor of OC90


  • Gene

    zinc finger protein 398


  • Gene

    CECR2 histone acetyl-lysine reader


  • Gene

    cystathionine beta-synthase like

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.